Protocol for a double-blind placebo-controlled randomised controlled trial assessing the impact of oral semaglutide in amyloid positivity (ISAP) in community dwelling UK adults.
Journal article
Koychev I. et al, (2024), BMJ Open, 14
Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91).
Journal article
Adler AI. et al, (2024), Lancet
Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data.
Journal article
Bidulka P. et al, (2024), BMJ, 385
Overcoming challenges in the economic evaluation of interventions to optimise antibiotic use
Journal article
ROOPE L. et al, (2024), Communications Medicine
ASCEND-Eye: Effects of Omega-3 Fatty Acids on Diabetic Retinopathy.
Journal article
Sammons EL. et al, (2024), Ophthalmology, 131, 526 - 533
ASCEND-Eye: Effects of Aspirin on Diabetic Retinopathy.
Journal article
Sammons EL. et al, (2024), Ophthalmology
Diabetes mellitus in Kabuki syndrome 1 on a background of post-transplant diabetes mellitus.
Journal article
Chew Sue Mei S. et al, (2024), Endocrinology, diabetes & metabolism case reports, 2024, 23 - 133
Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin: The Randomized, Controlled EMPA-VISION Trial.
Journal article
Hundertmark MJ. et al, (2023), Circulation, 147, 1654 - 1669
Time-dependent event accumulation in a cardiovascular outcome trial of patients with type 2 diabetes and established atherosclerotic cardiovascular disease.
Journal article
Bethel MA. et al, (2023), Cardiovasc Diabetol, 22
Teplizumab approval for type 1 diabetes in the USA.
Journal article
Beran D. et al, (2023), Lancet Diabetes Endocrinol, 11, 78 - 80
What, Where, and How to Collect Real-World Data and Generate Real-World Evidence to Support Drug Reimbursement Decision-Making in Asia: A reflection Into the Past and A Way Forward
Journal article
Kc S. et al, (2023), International Journal of Health Policy and Management, 12
Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes - Authors' reply.
Journal article
Nazarzadeh M. et al, (2022), Lancet Diabetes Endocrinol, 10, 841 - 842
New ways of evaluating and purchasing antimicrobials.
Journal article
Adler A. et al, (2022), Lancet Infect Dis, 22
Calibrating a network meta-analysis of diabetes trials of sodium glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population: a systematic review protocol.
Journal article
Butterly E. et al, (2022), BMJ Open, 12
Endpoints and estimands: understanding trials of weight-loss drugs.
Journal article
Adler AI., (2022), Nat Med, 28, 2005 - 2006
How can we optimise health technology assessment and reimbursement decisions to accelerate access to new cardiovascular medicines?
Journal article
Cowie MR. et al, (2022), International journal of cardiology, 365, 61 - 68
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis.
Journal article
Nazarzadeh M. et al, (2022), Lancet Diabetes Endocrinol, 10, 645 - 654
Ethnic and socioeconomic disparities in initiation of second-line antidiabetic treatment for people with type 2 diabetes in England: A cross-sectional study.
Journal article
Bidulka P. et al, (2022), Diabetes, obesity & metabolism
NICE guidelines on nivolumab plus ipilimumab for untreated, unresectable malignant pleural mesothelioma.
Journal article
Adler AI. et al, (2022), Lancet Respir Med